Press Releases
 
Sarcoma Market – Latest Trends and Future Growth Study by 2026

, 24 May 2019 -- Sarcoma is rare kind of cancer that occurs in the connective tissues of the body. Normal connective tissue include blood vessels, fat, nerves, muscles, deep skin tissues, bones, and cartilage. There are more than 50 types of sarcomas. However, they are mainly classified into two types: soft tissue sarcomas and bone sarcomas. They are further divided based on presumed cell of origin found in the tumor. Soft tissue sarcoma is the most common type of sarcoma, accounting for more than 80% of all sarcoma cases. Sarcoma affects all age groups but is more common in children. It is estimated that about 15% of cancer diagnosis in children are sarcomas. Rise in the incidence and prevalence of sarcoma, strong clinical pipeline of sarcoma drugs, rise in government initiatives toward orphan drug development, and increase in research and development expenditure are likely to fuel the growth of the global sarcoma market during forecast period. However, disappointing results of promising pipeline molecules, high cost of treatment and side effect associated with it, and stringent government regulations are estimated to hamper the growth of the global sarcoma market in in the coming years.

Read Report Overview:

https://www.transparencymarketresearch.com/sarcoma-market.html

The global sarcoma market can be segmented based on type, treatment, and geography. Based on type, the sarcoma market can be segmented into soft tissue sarcoma and bone sarcoma. The soft tissue sarcoma segment is expected to hold a significant share of the market during forecast period, owing to high incidence and prevalence rate of soft tissue sarcoma. In terms of treatment, the global sarcoma market can be categorized into chemotherapy, surgery, radiation therapy, and others (stem cell therapy). The chemotherapy segment generally includes a combination of various anti-neoplastic drugs. The commonly used chemotherapeutics agents are dactinomycin, etoposide, irinotecan, doxorubicin, carboplatin, ifosfamide, vincristine, among others. The chemotherapy segment expected to account for a significant share of the market during forecast period due to high cost of chemotherapy and it preference as the first line therapy for the treatment of sarcoma. Rise in the incidence and prevalence of sarcoma, increase in demand for targeted therapy and personalized therapy, and significant pipeline molecules (such as afatinib and temsirolimus) are likely to propel the market in the near future. Furthermore, development of new products with improved efficacy as a part of growth strategies adopted by a number of players and strategic deals, mergers, and acquisitions in the sarcoma market are estimated to drive the market in the next few years.

In terms of geography, the global sarcoma market can be segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is anticipated to be a dominant region of the market, followed by Europe. The high incidence of sarcoma (around 15,000 new cases are diagnosed each year in the U.S.), growing awareness among people, increase in research and development expenditure, strong clinical pipeline, and well-established health care infrastructure contribute to the growth of the sarcoma market in North America. The market in Asia Pacific is anticipated to expand at a high CAGR during the forecast period. The market is likely to be driven by India and China, owing to a significant patient base, increased government initiatives, and developing health care infrastructure. The market in Latin America and Middle East & Africa is anticipated to expand during the forecast period, owing to an increase in investments from market players in these regions and increase in prevalence of sarcoma.

Request Brochure of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=52404

The leading players in the global sarcoma market include Eli Lilly and Company, CytRx, Boehringer Ingelheim, Ovation Pharmaceuticals, Inc., Pfizer, Tracon Pharma, Karyopharm Therapeutics, Blueprint Medicines, Advenchen Laboratories, Oasmia Pharmaceutical, and Arog Pharmaceuticals.

About us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
Website: https://www.transparencymarketresearch.com/



# # #


Submitted by hawer on Friday, 24 May 2019 at 2:34 AM
Category: Health Care & Medical
 
Related News

Low Testosterone? Try these all-natural tips from NJ’s leading Holistic Doctor, Michael Rothma
Friday, 21 Jun 2019

Amoxicillin Market Competitive Landscape Analysis with Forecast by 2026
Friday, 21 Jun 2019

Botanicals Market Scope and Opportunities Analysis 2018-2026
Friday, 21 Jun 2019

Compression Garments Market to Set Phenomenal Growth from 2018 to 2026
Friday, 21 Jun 2019

Micro-hospitals Market to Witness Steady Expansion During 2018 - 2026
Thursday, 20 Jun 2019

Related Events

Vestibular Schwannoma Conference 2019
Wednesday, 19 Jun 2019

2nd International Public Mental Health Conference
Wednesday, 19 Jun 2019

III World Congress and VI International Congress on Dual Disorders ICDD2019
Wednesday, 19 Jun 2019

8th Annual HPAPI Summit
Wednesday, 19 Jun 2019

World Congress on Thyroid Cancer 3.5
Thursday, 20 Jun 2019

Latest News

Low Testosterone? Try these all-natural tips from NJ’s leading Holistic Doctor, Michael Rothma
Friday, 21 Jun 2019

Amoxicillin Market Competitive Landscape Analysis with Forecast by 2026
Friday, 21 Jun 2019

Botanicals Market Scope and Opportunities Analysis 2018-2026
Friday, 21 Jun 2019

Compression Garments Market to Set Phenomenal Growth from 2018 to 2026
Friday, 21 Jun 2019

Andarine (S-4)
Friday, 21 Jun 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Friday, 21 June 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Vestibular Schwannoma Conference 2019
  • Palo Alto Networks: May - Palo Alto Networks Heads-up
  • 2nd International Public Mental Health Conference
  • III World Congress and VI International Congress on Dual Disorders ICDD2019
  • Hi And Fi Asia-China 2019

  • Latest Jobs
    Sorry, there are currently no entries posted here.